Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Abbott Labs is reviewing the ad account of its Humira arthritis medication, according to sources. The incumbent is Omnicom Group medical specialty shop Harrison & Star, based here.
Executives at the incumbent were not available for comment, and it could not immediately be determined if H&S was defending. A client rep said only: “This is not the kind of thing we talk about. I can’t confirm or comment.”
Last year, Abbott increased ad spending on Humira 13 percent to $70 million, per Nielsen Monitor-Plus.
In
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in